ATE227132T1 - Zusammensetzung die mindestens einem doppel strangiger rna mit mindestens einem 6- benzyluracile derivat enthält für eine gleichzeitige, getrennte oder zeitausgelegte therapeutische verwendung - Google Patents

Zusammensetzung die mindestens einem doppel strangiger rna mit mindestens einem 6- benzyluracile derivat enthält für eine gleichzeitige, getrennte oder zeitausgelegte therapeutische verwendung

Info

Publication number
ATE227132T1
ATE227132T1 AT98941526T AT98941526T ATE227132T1 AT E227132 T1 ATE227132 T1 AT E227132T1 AT 98941526 T AT98941526 T AT 98941526T AT 98941526 T AT98941526 T AT 98941526T AT E227132 T1 ATE227132 T1 AT E227132T1
Authority
AT
Austria
Prior art keywords
derivative
benzyluracile
simultaneous
separate
composition containing
Prior art date
Application number
AT98941526T
Other languages
English (en)
Inventor
Eric Ruhlmann
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of ATE227132T1 publication Critical patent/ATE227132T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98941526T 1997-08-04 1998-08-03 Zusammensetzung die mindestens einem doppel strangiger rna mit mindestens einem 6- benzyluracile derivat enthält für eine gleichzeitige, getrennte oder zeitausgelegte therapeutische verwendung ATE227132T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709974A FR2766711B1 (fr) 1997-08-04 1997-08-04 Produit comprenant au moins un arn double brin en association avec au moins un devire du 6-benzyluracile pour une utilisation therapeutique simultanee, separee ou etalee dans le temps
PCT/FR1998/001726 WO1999007384A1 (fr) 1997-08-04 1998-08-03 Produit comprenant au moins un arn double brin en association avec au moins un derive du 6-benzyluracile

Publications (1)

Publication Number Publication Date
ATE227132T1 true ATE227132T1 (de) 2002-11-15

Family

ID=9510012

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98941526T ATE227132T1 (de) 1997-08-04 1998-08-03 Zusammensetzung die mindestens einem doppel strangiger rna mit mindestens einem 6- benzyluracile derivat enthält für eine gleichzeitige, getrennte oder zeitausgelegte therapeutische verwendung

Country Status (10)

Country Link
EP (1) EP1001789B1 (de)
AT (1) ATE227132T1 (de)
AU (1) AU8987198A (de)
DE (1) DE69809246T2 (de)
DK (1) DK1001789T3 (de)
ES (1) ES2187056T3 (de)
FR (1) FR2766711B1 (de)
NO (1) NO20000554L (de)
PT (1) PT1001789E (de)
WO (1) WO1999007384A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases

Also Published As

Publication number Publication date
EP1001789B1 (de) 2002-11-06
WO1999007384A1 (fr) 1999-02-18
NO20000554D0 (no) 2000-02-03
DE69809246T2 (de) 2003-08-28
ES2187056T3 (es) 2003-05-16
DE69809246D1 (de) 2002-12-12
AU8987198A (en) 1999-03-01
DK1001789T3 (da) 2003-03-10
FR2766711B1 (fr) 2001-02-02
PT1001789E (pt) 2003-03-31
FR2766711A1 (fr) 1999-02-05
NO20000554L (no) 2000-02-03
EP1001789A1 (de) 2000-05-24

Similar Documents

Publication Publication Date Title
ATE268547T1 (de) Auf tensiden basierende antimikrobielle zusammensetzungen und verfahren zu ihrer verwendung
DE69104796D1 (de) Zusammensetzung für die Haarbehandlung.
ATE212218T1 (de) Topische zusammensetzungen mit verbessertem hautgefühl
HUP0003351A3 (en) 2-substituted 4,5-diaryl imidazoles, process for producing them, pharmaceutical compositions containing them and their use
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
BR9205142A (pt) Composicao inseticida,e,processo para produzi-la
FI972703L (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
PT1033990E (pt) 21-hidroxi-6,19-oxidoprogesterona (21oh-6op) e a sua utilizacao como medicamento para tratar o excesso de glucocorticoides
DE69501978D1 (de) Rollvorrichtung für längliche Gegenstände, insbesondere für die Herstellung von Tabakprodukten
FI920760A0 (fi) In vitro packningsystem foer kloning av dna-fragment med 95 kb.
DE69942830D1 (de) Lieferung von gewünschter sevicepolitik für teilnehmer die zum internet zugriff haben
SE9802937D0 (sv) Novel compounds
WO1999041364A3 (en) Compositions and methods for wound healing
DE69009196D1 (de) EEPROM, dessen Löschgate-Elektrodenmuster, die Muster des Source-Bereiches kreuzen und Verfahren zur Herstellung desselben.
MX9202366A (es) Nuevas 2-amino-5-ciano-1,4-di hidro piridinas y procedimiento para su fabricacion.
DE69809246D1 (de) Zusammensetzung die mindestens einem doppel strangiger rna mit mindestens einem 6-benzyluracile derivat enthält für eine gleichzeitige, getrennte oder zeitausgelegte therapeutische verwendung
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
DE59002772D1 (de) Verwendung von Dextransulfat, gegebenenfalls in Kombination mit anti-androgenen Mitteln zur Behandlung des humanen Protatakarzinoms.
DE69711084D1 (de) Absorbierbare zusammensetzung enthaltend propionäure bakterien die fähig sind, stickstoffoxid in dem menschlichen oder tierischen verdauungstrakt zu produzieren
DE69025308D1 (de) Enzyme die teilnehmen an c-endamidierung, herstellung und verwendung
ITMI941696A0 (it) 8-fluoro-antracicline, loro processi di preparazione e composizioni farmaceutiche che le contengono
BR9603767A (pt) Processo para revestir couro e composição para executar o mesmo
IT1268346B1 (it) Metodo per la fabbricazione di ferri da stiro con soletta in acciaio
ITMI942023A0 (it) 6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono
DE69002821D1 (de) Zusammensetzung zur haarbehandlung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1001789

Country of ref document: EP

REN Ceased due to non-payment of the annual fee